HYPR

Hyperfine, Inc. HYPR

HYPR
Hyperfine, Inc. ELMD
Electromed, Inc. LUCD
Lucid Diagnostics Inc. NPCE
NeuroPace, Inc. KIDS
OrthoPediatrics Corp. CVRX
CVRx, Inc. HSCS
HeartSciences Inc. JSPR
Jasper Therapeutics, Inc. REVB
Revelation Biosciences, Inc. BGXX
Bright Green Corporation

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HYPR ELMD LUCD NPCE KIDS CVRX HSCS JSPR REVB BGXX
6M 138.68 % 6.97 % -1.71 % -1.34 % -22.97 % 43.66 % 1.16 % -42.31 % -85.12 % 0.00 %
YTD 78.57 % -19.93 % 44.84 % -11.23 % -28.73 % -34.09 % -6.68 % -88.62 % -95.50 % -33.57 %
1Y 76.00 % 6.17 % 47.55 % 59.13 % -37.19 % 13.58 % -2.51 % -85.52 % -96.26 % -71.85 %
3Y 53.32 % 133.98 % -33.53 % 226.35 % -61.01 % -1.97 % -97.40 % -69.62 % -99.99 % -94.57 %
5Y -82.52 % 171.40 % -90.22 % -58.81 % -64.56 % -68.04 % -97.95 % -97.58 % -100.00 % -99.85 %
10Y -82.52 % 1 209.78 % -90.22 % -58.81 % -15.19 % -68.04 % -97.95 % -97.56 % -100.00 % -99.85 %
From the beginning -82.52 % 505.53 % -90.22 % -58.81 % -15.19 % -68.04 % -97.95 % -97.56 % -100.00 % -99.85 %

Dividend